People
The IQVIA Institute for Human Data Science is releasing its 2019 “Global Oncology Trends” report simultaneously with the American Society of Clinical Oncology (ASCO) Meeting.
Ultragenyx Pharmaceutical Inc. announced that the Biotechnology Innovation Organization (BIO) has awarded this year’s Henri A. Termeer Biotechnology Visionary Award to Emil D. Kakkis, M.D., Ph.D., Chief Executive Officer, President and founder of Ultragenyx.
Dynavax plans to step away from immuno-oncology development and will lay off 37% of its staff as a result.
CENTOGENE welcomed Germany’s Chancellor Dr. Angela Merkel to its headquarters together with Manuela Schwesig, Minister-President of Mecklenburg-Vorpommern.
BioArctic AB announced that the company has recruited the internationally renowned scientist Dr. Per-Ola Freskgård to strengthen BioArctic’s development of its technology platform to facilitate passage of antibodies and other biologics across the blood-brain barrier.
Biopharma companies from across the globe strengthen their leadership teams with key executive appointments.
Pharma and biotech companies have been developing cutting-edge treatments and medications for a myriad of diseases but, for some patients, getting those medications has become a herculean task.
A paper published by Tillman Gerngross, chief executive officer of Adimab LLC, alleged that an MIT professor’s work was nearly identical to work published several years before his.
Joins MD Anderson from University Health Network/Princess Margaret Cancer Centre
Appointment of Mr Vince Ippolito, a US-based dermatology industry leader with over 30 years of pharmaceuticals experience as President of Botanix
PRESS RELEASES